Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	microfilament motor activity	MYH1 MYH2 MYH4 MYH6 MYH7 MYH13 MYH15	6.33e-12	38	52	7	GO:0000146
GeneOntologyMolecularFunction	cytoskeletal motor activity	MYH1 MYH2 MYH4 MYH6 MYH7 MYH13 MYH15 DNAH8	7.09e-10	118	52	8	GO:0003774
GeneOntologyMolecularFunction	ATP-dependent activity	MYH1 MYH2 MYH4 MYH6 MYH7 SETX MYH13 ABCB9 MYH15 CHD1 DNAH8	4.08e-07	614	52	11	GO:0140657
GeneOntologyMolecularFunction	actin filament binding	MYH1 MYH2 MYH4 MYH6 MYH7 MYH13 MYH15	1.94e-06	227	52	7	GO:0051015
GeneOntologyMolecularFunction	calmodulin binding	MYH1 MYH2 MYH4 MYH6 MYH7 MYH13 MYH15	2.11e-06	230	52	7	GO:0005516
GeneOntologyMolecularFunction	aminopeptidase activity	BLMH DPP9 XPNPEP2	1.91e-04	43	52	3	GO:0004177
GeneOntologyMolecularFunction	actin binding	MYH1 MYH2 MYH4 MYH6 MYH7 MYH13 MYH15	2.30e-04	479	52	7	GO:0003779
GeneOntologyMolecularFunction	benzodiazepine receptor activity	TSPO GABRA4	3.60e-04	11	52	2	GO:0008503
GeneOntologyMolecularFunction	sterol binding	TSPO OSBPL11 VDAC2	8.40e-04	71	52	3	GO:0032934
GeneOntologyMolecularFunction	polypeptide N-acetylgalactosaminyltransferase activity	GALNT12 GALNT4	1.23e-03	20	52	2	GO:0004653
GeneOntologyBiologicalProcess	muscle filament sliding	MYH2 MYH4 MYH6 MYH7	4.80e-08	15	52	4	GO:0030049
GeneOntologyBiologicalProcess	actin-myosin filament sliding	MYH2 MYH4 MYH6 MYH7	1.07e-07	18	52	4	GO:0033275
GeneOntologyBiologicalProcess	peptidyl-threonine modification	EOGT CSNK2A1 CSNK2A2 TTK GALNT4	1.56e-05	125	52	5	GO:0018210
GeneOntologyBiologicalProcess	purine ribonucleoside triphosphate metabolic process	MYH4 MYH6 MYH7 TSPO CTNS MFN1	7.58e-05	283	52	6	GO:0009205
GeneOntologyBiologicalProcess	ribonucleoside triphosphate metabolic process	MYH4 MYH6 MYH7 TSPO CTNS MFN1	8.67e-05	290	52	6	GO:0009199
GeneOntologyBiologicalProcess	purine nucleoside triphosphate metabolic process	MYH4 MYH6 MYH7 TSPO CTNS MFN1	8.84e-05	291	52	6	GO:0009144
GeneOntologyBiologicalProcess	nucleoside triphosphate metabolic process	MYH4 MYH6 MYH7 TSPO CTNS MFN1	1.19e-04	307	52	6	GO:0009141
GeneOntologyBiologicalProcess	negative regulation of proteasomal ubiquitin-dependent protein catabolic process	HFE CSNK2A1 CSNK2A2	1.62e-04	42	52	3	GO:0032435
GeneOntologyBiologicalProcess	carbohydrate derivative metabolic process	MYH4 MYH6 MYH7 EOGT TSPO GALNT12 CTNS DSE GALNT4 MFN1 ELOVL7	1.98e-04	1226	52	11	GO:1901135
GeneOntologyBiologicalProcess	protein O-linked glycosylation via threonine	EOGT GALNT4	2.77e-04	10	52	2	GO:0018243
GeneOntologyBiologicalProcess	purine ribonucleotide metabolic process	MYH4 MYH6 MYH7 TSPO CTNS MFN1 ELOVL7	2.84e-04	512	52	7	GO:0009150
GeneOntologyBiologicalProcess	actin-mediated cell contraction	MYH2 MYH4 MYH6 MYH7	2.95e-04	127	52	4	GO:0070252
GeneOntologyBiologicalProcess	ribonucleotide metabolic process	MYH4 MYH6 MYH7 TSPO CTNS MFN1 ELOVL7	3.61e-04	533	52	7	GO:0009259
GeneOntologyBiologicalProcess	ribose phosphate metabolic process	MYH4 MYH6 MYH7 TSPO CTNS MFN1 ELOVL7	3.91e-04	540	52	7	GO:0019693
GeneOntologyBiologicalProcess	ATP metabolic process	MYH4 MYH6 MYH7 TSPO CTNS	4.66e-04	257	52	5	GO:0046034
GeneOntologyBiologicalProcess	negative regulation of proteasomal protein catabolic process	HFE CSNK2A1 CSNK2A2	4.91e-04	61	52	3	GO:1901799
GeneOntologyBiologicalProcess	negative regulation of ubiquitin-dependent protein catabolic process	HFE CSNK2A1 CSNK2A2	4.91e-04	61	52	3	GO:2000059
GeneOntologyBiologicalProcess	muscle contraction	MYH1 MYH2 MYH4 MYH6 MYH7 MYH13	4.91e-04	400	52	6	GO:0006936
GeneOntologyBiologicalProcess	actin filament-based movement	MYH2 MYH4 MYH6 MYH7	5.98e-04	153	52	4	GO:0030048
GeneOntologyBiologicalProcess	positive regulation of mitochondrial membrane potential	CTNS MFN1	7.31e-04	16	52	2	GO:0010918
GeneOntologyCellularComponent	myosin filament	MYH1 MYH2 MYH4 MYH6 MYH7 MYH13 MYH15	1.56e-13	25	51	7	GO:0032982
GeneOntologyCellularComponent	myosin II complex	MYH1 MYH2 MYH4 MYH6 MYH7 MYH13 MYH15	3.81e-13	28	51	7	GO:0016460
GeneOntologyCellularComponent	muscle myosin complex	MYH1 MYH2 MYH4 MYH6 MYH7 MYH13	1.22e-12	16	51	6	GO:0005859
GeneOntologyCellularComponent	myosin complex	MYH1 MYH2 MYH4 MYH6 MYH7 MYH13 MYH15	1.04e-10	59	51	7	GO:0016459
GeneOntologyCellularComponent	myofibril	MYH1 MYH2 MYH4 MYH6 MYH7 MYH13 MYH15	4.25e-06	273	51	7	GO:0030016
GeneOntologyCellularComponent	contractile muscle fiber	MYH1 MYH2 MYH4 MYH6 MYH7 MYH13 MYH15	6.32e-06	290	51	7	GO:0043292
GeneOntologyCellularComponent	actin cytoskeleton	HFE MYH1 MYH2 MYH4 MYH6 MYH7 MYH13 MYH15 KLHL14	9.32e-06	576	51	9	GO:0015629
GeneOntologyCellularComponent	protein kinase CK2 complex	CSNK2A1 CSNK2A2	3.49e-05	4	51	2	GO:0005956
GeneOntologyCellularComponent	sarcomere	MYH1 MYH2 MYH4 MYH6 MYH7	3.46e-04	249	51	5	GO:0030017
GeneOntologyCellularComponent	supramolecular fiber	MYH1 MYH2 MYH4 MYH6 MYH7 DPP9 MYH13 MYH15 DNAH8	2.00e-03	1179	51	9	GO:0099512
GeneOntologyCellularComponent	supramolecular polymer	MYH1 MYH2 MYH4 MYH6 MYH7 DPP9 MYH13 MYH15 DNAH8	2.09e-03	1187	51	9	GO:0099081
HumanPheno	Elevated jugular venous pressure	HFE MYH7	5.53e-05	4	16	2	HP:0030848
HumanPheno	Abnormal jugular venous pressure	HFE MYH7	5.53e-05	4	16	2	HP:0030847
Domain	Myosin_N	MYH1 MYH2 MYH4 MYH6 MYH7 MYH13 MYH15	5.39e-15	15	52	7	IPR004009
Domain	Myosin_N	MYH1 MYH2 MYH4 MYH6 MYH7 MYH13 MYH15	5.39e-15	15	52	7	PF02736
Domain	Myosin_tail_1	MYH1 MYH2 MYH4 MYH6 MYH7 MYH13 MYH15	2.65e-14	18	52	7	PF01576
Domain	Myosin_tail	MYH1 MYH2 MYH4 MYH6 MYH7 MYH13 MYH15	2.65e-14	18	52	7	IPR002928
Domain	Myosin-like_IQ_dom	MYH1 MYH2 MYH4 MYH6 MYH7 MYH13 MYH15	4.18e-14	19	52	7	IPR027401
Domain	-	MYH1 MYH2 MYH4 MYH6 MYH7 MYH13 MYH15	4.18e-14	19	52	7	4.10.270.10
Domain	MYOSIN_MOTOR	MYH1 MYH2 MYH4 MYH6 MYH7 MYH13 MYH15	1.01e-11	38	52	7	PS51456
Domain	Myosin_head	MYH1 MYH2 MYH4 MYH6 MYH7 MYH13 MYH15	1.01e-11	38	52	7	PF00063
Domain	Myosin_head_motor_dom	MYH1 MYH2 MYH4 MYH6 MYH7 MYH13 MYH15	1.01e-11	38	52	7	IPR001609
Domain	MYSc	MYH1 MYH2 MYH4 MYH6 MYH7 MYH13 MYH15	1.01e-11	38	52	7	SM00242
Domain	IQ	MYH1 MYH2 MYH4 MYH6 MYH7 MYH13 MYH15	6.73e-09	93	52	7	PS50096
Domain	IQ	MYH1 MYH2 MYH4 MYH6 MYH7 MYH13	9.57e-08	81	52	6	SM00015
Domain	IQ_motif_EF-hand-BS	MYH1 MYH2 MYH4 MYH6 MYH7 MYH13	1.80e-07	90	52	6	IPR000048
Domain	IQ	MYH1 MYH2 MYH4 MYH6 MYH13	1.56e-06	71	52	5	PF00612
Domain	P-loop_NTPase	MYH1 MYH2 MYH4 MYH6 MYH7 SETX MYH13 ABCB9 MYH15 CHD1 DNAH8 MFN1	2.74e-06	848	52	12	IPR027417
Domain	-	NLN THOP1	2.28e-05	3	52	2	1.20.1050.40
Domain	Pept_M3A_M3B	NLN THOP1	2.28e-05	3	52	2	IPR001567
Domain	-	NLN THOP1	2.28e-05	3	52	2	1.10.1370.10
Domain	Neurolysin/TOP_N	NLN THOP1	2.28e-05	3	52	2	IPR024080
Domain	Neurolysin/TOP_dom2	NLN THOP1	2.28e-05	3	52	2	IPR024077
Domain	Peptidase_M3	NLN THOP1	2.28e-05	3	52	2	PF01432
Domain	Ricin_B_lectin	GALNT12 GALNT4	2.19e-03	25	52	2	PF00652
Domain	RICIN	GALNT12 GALNT4	2.74e-03	28	52	2	SM00458
Domain	RICIN_B_LECTIN	GALNT12 GALNT4	2.74e-03	28	52	2	PS50231
Domain	Pept_cys_AS	BLMH DNAH8	2.74e-03	28	52	2	IPR000169
Domain	Glyco_trans_2-like	GALNT12 GALNT4	3.15e-03	30	52	2	IPR001173
Domain	Ricin_B_lectin	GALNT12 GALNT4	3.15e-03	30	52	2	IPR000772
Domain	Glycos_transf_2	GALNT12 GALNT4	3.15e-03	30	52	2	PF00535
Pathway	KEGG_TIGHT_JUNCTION	MYH1 MYH2 MYH4 MYH6 MYH7 MYH13 CSNK2A1 CSNK2A2 MYH15	5.44e-11	132	38	9	M11355
Pathway	KEGG_VIRAL_MYOCARDITIS	MYH1 MYH2 MYH4 MYH6 MYH7 MYH13 MYH15	6.11e-10	70	38	7	M12294
Pathway	REACTOME_MITOPHAGY	CSNK2A1 CSNK2A2 MFN1 VDAC2	3.45e-06	39	38	4	M27418
Pathway	REACTOME_MITOPHAGY	CSNK2A1 CSNK2A2 MFN1 VDAC2	4.23e-06	41	38	4	MM15166
Pathway	REACTOME_SELECTIVE_AUTOPHAGY	CSNK2A1 CSNK2A2 MFN1 VDAC2	4.28e-05	73	38	4	MM15672
Pathway	REACTOME_SELECTIVE_AUTOPHAGY	CSNK2A1 CSNK2A2 MFN1 VDAC2	9.71e-05	90	38	4	M29841
Pathway	KEGG_MEDICUS_REFERENCE_INACTIVATION_OF_CONDENSIN_I	CSNK2A1 CSNK2A2	1.05e-04	6	38	2	M47878
Pathway	REACTOME_WNT_MEDIATED_ACTIVATION_OF_DVL	CSNK2A1 CSNK2A2	1.96e-04	8	38	2	M27100
Pathway	REACTOME_CONDENSATION_OF_PROMETAPHASE_CHROMOSOMES	CSNK2A1 CSNK2A2	1.96e-04	8	38	2	MM14895
Pathway	REACTOME_WNT_MEDIATED_ACTIVATION_OF_DVL	CSNK2A1 CSNK2A2	2.52e-04	9	38	2	MM14792
Pathway	REACTOME_CONDENSATION_OF_PROMETAPHASE_CHROMOSOMES	CSNK2A1 CSNK2A2	3.83e-04	11	38	2	M27182
Pathway	REACTOME_RECEPTOR_MEDIATED_MITOPHAGY	CSNK2A1 CSNK2A2	3.83e-04	11	38	2	M27789
Pathway	REACTOME_MACROAUTOPHAGY	CSNK2A1 CSNK2A2 MFN1 VDAC2	4.00e-04	130	38	4	MM14627
Pathway	KEGG_MEDICUS_REFERENCE_BLOCKING_UBIQUITINATION_OF_H2AK119_BY_CK2	CSNK2A1 CSNK2A2	4.59e-04	12	38	2	M47943
Pathway	REACTOME_RECEPTOR_MEDIATED_MITOPHAGY	CSNK2A1 CSNK2A2	4.59e-04	12	38	2	MM15525
Pathway	KEGG_MEDICUS_VARIANT_OLIGOMERIC_CONFORMATION_PRPC_TO_ANTEROGRADE_AXONAL_TRANSPORT	CSNK2A1 CSNK2A2	5.42e-04	13	38	2	M47763
Pathway	BIOCARTA_LIS1_PATHWAY	CSNK2A1 CSNK2A2	6.31e-04	14	38	2	MM1531
Pathway	REACTOME_RESPIRATORY_SYNCYTIAL_VIRUS_RSV_GENOME_REPLICATION_TRANSCRIPTION_AND_TRANSLATION	CSNK2A1 CSNK2A2	8.29e-04	16	38	2	M48235
Pathway	PID_DNA_PK_PATHWAY	CSNK2A1 CSNK2A2	8.29e-04	16	38	2	M42
Pathway	REACTOME_AUTOPHAGY	CSNK2A1 CSNK2A2 MFN1 VDAC2	8.33e-04	158	38	4	M27935
Pathway	PID_NFKAPPAB_ATYPICAL_PATHWAY	CSNK2A1 CSNK2A2	9.38e-04	17	38	2	M26
Pathway	KEGG_RENIN_ANGIOTENSIN_SYSTEM	NLN THOP1	9.38e-04	17	38	2	M17636
Pathway	REACTOME_SIGNAL_TRANSDUCTION_BY_L1	CSNK2A1 CSNK2A2	1.18e-03	19	38	2	MM15113
Pathway	BIOCARTA_LIS1_PATHWAY	CSNK2A1 DNAH8	1.18e-03	19	38	2	M22005
Pathway	BIOCARTA_EPO_PATHWAY	CSNK2A1 CSNK2A2	1.30e-03	20	38	2	MM1389
Pathway	REACTOME_SIGNAL_TRANSDUCTION_BY_L1	CSNK2A1 CSNK2A2	1.44e-03	21	38	2	M878
Pathway	BIOCARTA_IGF1_PATHWAY	CSNK2A1 CSNK2A2	1.58e-03	22	38	2	MM1409
Pathway	BIOCARTA_IL6_PATHWAY	CSNK2A1 CSNK2A2	1.58e-03	22	38	2	MM1415
Pathway	BIOCARTA_NGF_PATHWAY	CSNK2A1 CSNK2A2	1.58e-03	22	38	2	MM1440
Pathway	BIOCARTA_WNT_PATHWAY	CSNK2A1 CSNK2A2	1.73e-03	23	38	2	MM1527
Pathway	BIOCARTA_IL2_PATHWAY	CSNK2A1 CSNK2A2	1.73e-03	23	38	2	MM1411
Pathway	BIOCARTA_INSULIN_PATHWAY	CSNK2A1 CSNK2A2	1.88e-03	24	38	2	MM1425
Pathway	BIOCARTA_TPO_PATHWAY	CSNK2A1 CSNK2A2	2.04e-03	25	38	2	MM1519
Pathway	REACTOME_SYNTHESIS_OF_PC	CSNK2A1 CSNK2A2	2.21e-03	26	38	2	MM14584
Pathway	REACTOME_PROTEIN_FOLDING	CSNK2A1 CSNK2A2 WRAP53	2.30e-03	98	38	3	M776
Pathway	REACTOME_SYNTHESIS_OF_PC	CSNK2A1 CSNK2A2	2.56e-03	28	38	2	M684
Pathway	BIOCARTA_EGF_PATHWAY	CSNK2A1 CSNK2A2	2.56e-03	28	38	2	MM1386
Pathway	BIOCARTA_PDGF_PATHWAY	CSNK2A1 CSNK2A2	2.74e-03	29	38	2	MM1452
Pathway	KEGG_O_GLYCAN_BIOSYNTHESIS	GALNT12 GALNT4	2.93e-03	30	38	2	M6929
Pathway	REACTOME_PINK1_PRKN_MEDIATED_MITOPHAGY	MFN1 VDAC2	3.33e-03	32	38	2	M27419
Pathway	REACTOME_RUNX1_INTERACTS_WITH_CO_FACTORS_WHOSE_PRECISE_EFFECT_ON_RUNX1_TARGETS_IS_NOT_KNOWN	CSNK2A1 CSNK2A2	3.76e-03	34	38	2	MM15531
Pathway	REACTOME_PINK1_PRKN_MEDIATED_MITOPHAGY	MFN1 VDAC2	3.76e-03	34	38	2	MM15167
Pathway	REACTOME_RUNX1_INTERACTS_WITH_CO_FACTORS_WHOSE_PRECISE_EFFECT_ON_RUNX1_TARGETS_IS_NOT_KNOWN	CSNK2A1 CSNK2A2	4.44e-03	37	38	2	M27797
Pathway	REACTOME_COOPERATION_OF_PDCL_PHLP1_AND_TRIC_CCT_IN_G_PROTEIN_BETA_FOLDING	CSNK2A1 CSNK2A2	4.68e-03	38	38	2	M27656
Pathway	PID_P38_ALPHA_BETA_DOWNSTREAM_PATHWAY	CSNK2A1 CSNK2A2	4.68e-03	38	38	2	M229
Pathway	REACTOME_CHAPERONIN_MEDIATED_PROTEIN_FOLDING	CSNK2A1 CSNK2A2	4.92e-03	39	38	2	MM15003
Pathway	PID_ECADHERIN_NASCENT_AJ_PATHWAY	CSNK2A1 CSNK2A2	4.92e-03	39	38	2	M156
Pubmed	A fast Myosin super enhancer dictates muscle fiber phenotype through competitive interactions with Myosin genes.	MYH1 MYH2 MYH4 MYH7 MYH13	1.42e-13	7	53	5	35210422
Pubmed	Diversity in transcriptional start site selection and alternative splicing affects the 5'-UTR of mouse striated muscle myosin transcripts.	MYH1 MYH2 MYH4 MYH6 MYH7	1.42e-13	7	53	5	16819597
Pubmed	Comparative sequence analysis of the complete human sarcomeric myosin heavy chain family: implications for functional diversity.	MYH1 MYH2 MYH4 MYH13	4.80e-12	4	53	4	10388558
Pubmed	Loss of Prox1 in striated muscle causes slow to fast skeletal muscle fiber conversion and dilated cardiomyopathy.	MYH1 MYH2 MYH4 MYH6 MYH7	1.34e-11	14	53	5	24938781
Pubmed	Myosin heavy chain isoforms of the murine masseter muscle during pre- and post-natal development.	MYH1 MYH2 MYH4 MYH7	2.40e-11	5	53	4	12919077
Pubmed	A family of microRNAs encoded by myosin genes governs myosin expression and muscle performance.	MYH1 MYH2 MYH4 MYH6 MYH7	2.92e-11	16	53	5	19922871
Pubmed	Organization of human and mouse skeletal myosin heavy chain gene clusters is highly conserved.	MYH1 MYH2 MYH4 MYH13	7.19e-11	6	53	4	10077619
Pubmed	Distinct myogenic programs of embryonic and fetal mouse muscle cells: expression of the perinatal myosin heavy chain isoform in vitro.	MYH1 MYH2 MYH4 MYH7	7.19e-11	6	53	4	1728586
Pubmed	Spatial and temporal changes in myosin heavy chain gene expression in skeletal muscle development.	MYH1 MYH2 MYH4 MYH7	7.19e-11	6	53	4	10588881
Pubmed	ANKK1 is found in myogenic precursors and muscle fibers subtypes with glycolytic metabolism.	MYH1 MYH2 MYH4 MYH7	1.68e-10	7	53	4	29758057
Pubmed	Neuromuscular junction immaturity and muscle atrophy are hallmarks of the ColQ-deficient mouse, a model of congenital myasthenic syndrome with acetylcholinesterase deficiency.	MYH1 MYH2 MYH4 MYH7	3.35e-10	8	53	4	26993635
Pubmed	Genes for skeletal muscle myosin heavy chains are clustered and are not located on the same mouse chromosome as a cardiac myosin heavy chain gene.	MYH1 MYH4 MYH6 MYH7	3.35e-10	8	53	4	3864153
Pubmed	A Tcf4-positive mesodermal population provides a prepattern for vertebrate limb muscle patterning.	MYH1 MYH2 MYH4 MYH6	3.35e-10	8	53	4	14667415
Pubmed	GASP-2 overexpressing mice exhibit a hypermuscular phenotype with contrasting molecular effects compared to GASP-1 transgenics.	MYH1 MYH2 MYH4 MYH7	6.02e-10	9	53	4	31960486
Pubmed	Genome-wide mapping of Sox6 binding sites in skeletal muscle reveals both direct and indirect regulation of muscle terminal differentiation by Sox6.	MYH1 MYH2 MYH4 MYH6 MYH7	1.12e-09	31	53	5	21985497
Pubmed	Deletion of the protein kinase A/protein kinase G target SMTNL1 promotes an exercise-adapted phenotype in vascular smooth muscle.	MYH1 MYH2 MYH4 MYH7	1.57e-09	11	53	4	18310078
Pubmed	The histone code reader Spin1 controls skeletal muscle development.	MYH1 MYH2 MYH4 MYH7	1.57e-09	11	53	4	29168801
Pubmed	Calcineurin is necessary for the maintenance but not embryonic development of slow muscle fibers.	MYH1 MYH2 MYH4 MYH7	1.57e-09	11	53	4	16024798
Pubmed	Transition of myosin heavy chain isoforms in human laryngeal abductors following denervation.	MYH1 MYH2 MYH4	3.34e-09	3	53	3	26059207
Pubmed	Structural and developmental analysis of two linked myosin heavy chain genes.	MYH1 MYH2 MYH7	3.34e-09	3	53	3	1371481
Pubmed	The expression of myosin heavy chain (MHC) genes in human skeletal muscle is related to metabolic characteristics involved in the pathogenesis of type 2 diabetes.	MYH1 MYH2 MYH7	3.34e-09	3	53	3	21470888
Pubmed	Contractile protein gene expression in primary myotubes of embryonic mouse hindlimb muscles.	MYH1 MYH2 MYH4 MYH7	3.40e-09	13	53	4	8404542
Pubmed	Defective excitation-contraction coupling is partially responsible for impaired contractility in hindlimb muscles of Stac3 knockout mice.	MYH1 MYH2 MYH4 MYH7	4.76e-09	14	53	4	27184118
Pubmed	Myopathy associated LDB3 mutation causes Z-disc disassembly and protein aggregation through PKCα and TSC2-mTOR downregulation.	MYH1 MYH2 MYH4 MYH7	4.76e-09	14	53	4	33742095
Pubmed	Six homeoproteins and a Iinc-RNA at the fast MYH locus lock fast myofiber terminal phenotype.	MYH1 MYH2 MYH4 MYH7	6.48e-09	15	53	4	24852826
Pubmed	IKKα and alternative NF-κB regulate PGC-1β to promote oxidative muscle metabolism.	MYH1 MYH2 MYH4 MYH7	1.13e-08	17	53	4	22351927
Pubmed	Smooth muscle myosin light chain kinase expression in cardiac and skeletal muscle.	MYH1 MYH2 MYH4	1.34e-08	4	53	3	11029314
Pubmed	Two novel/ancient myosins in mammalian skeletal muscles: MYH14/7b and MYH15 are expressed in extraocular muscles and muscle spindles.	MYH4 MYH7 MYH15	1.34e-08	4	53	3	19948655
Pubmed	A human YAC transgene rescues craniofacial and neural tube development in PDGFRalpha knockout mice and uncovers a role for PDGFRalpha in prenatal lung growth.	MYH1 MYH2 MYH4	1.34e-08	4	53	3	11023856
Pubmed	Modulation of skeletal muscle fiber type by mitogen-activated protein kinase signaling.	MYH1 MYH2 MYH4	1.34e-08	4	53	3	18417546
Pubmed	Detection of Gene and Protein Expression in Mouse Embryos and Tissue Sections.	MYH1 MYH2 MYH4	3.33e-08	5	53	3	30737693
Pubmed	Developmental pattern of mouse skeletal myosin heavy chain gene transcripts in vivo and in vitro.	MYH1 MYH2 MYH4	3.33e-08	5	53	3	3829126
Pubmed	Sequential accumulation of mRNAs encoding different myosin heavy chain isoforms during skeletal muscle development in vivo detected with a recombinant plasmid identified as coding for an adult fast myosin heavy chain from mouse skeletal muscle.	MYH1 MYH2 MYH4	3.33e-08	5	53	3	6196357
Pubmed	Mitochondrial fusion directs cardiomyocyte differentiation via calcineurin and Notch signaling.	MYH6 MYH7 MFN1	3.33e-08	5	53	3	24091702
Pubmed	Sox6 is required for normal fiber type differentiation of fetal skeletal muscle in mice.	MYH1 MYH2 MYH7	3.33e-08	5	53	3	17584907
Pubmed	A new role for the calcineurin/NFAT pathway in neonatal myosin heavy chain expression via the NFATc2/MyoD complex during mouse myogenesis.	MYH1 MYH2 MYH4 MYH6	3.44e-08	22	53	4	24301466
Pubmed	A hypoplastic model of skeletal muscle development displaying reduced foetal myoblast cell numbers, increased oxidative myofibres and improved specific tension capacity.	MYH1 MYH2 MYH4	6.66e-08	6	53	3	20417199
Pubmed	A role for Insulin-like growth factor 2 in specification of the fast skeletal muscle fibre.	MYH1 MYH2 MYH4	6.66e-08	6	53	3	17559643
Pubmed	Multiplexed kinase interactome profiling quantifies cellular network activity and plasticity.	MYH1 MYH2 MYH6 MYH7 CCDC198 MYH13 CSNK2A1 CSNK2A2 MYH15 CHD1 TTK	1.04e-07	910	53	11	36736316
Pubmed	The brain expressed x-linked gene 1 (Bex1) regulates myoblast fusion.	MYH1 MYH2 MYH7	1.16e-07	7	53	3	26586200
Pubmed	Autophagy controls neonatal myogenesis by regulating the GH-IGF1 system through a NFE2L2- and DDIT3-mediated mechanism.	MYH1 MYH2 MYH4 MYH7	1.47e-07	31	53	4	30081710
Pubmed	Cell lineage- and expression-based inference of the roles of forkhead box transcription factor Foxc2 in craniofacial development.	MYH1 MYH2 MYH4	1.86e-07	8	53	3	33667029
Pubmed	Myosin heavy chain-embryonic regulates skeletal muscle differentiation during mammalian development.	MYH1 MYH2 MYH4 MYH7	1.90e-07	33	53	4	32094117
Pubmed	Extracellular matrix protein composition dynamically changes during murine forelimb development.	MYH1 MYH2 MYH4	5.47e-07	11	53	3	38303699
Pubmed	CAP2 deficiency delays myofibril actin cytoskeleton differentiation and disturbs skeletal muscle architecture and function.	MYH2 MYH4 MYH7	5.47e-07	11	53	3	30962377
Pubmed	Modulation of contractile protein gene expression in fetal murine crural muscles: emergence of muscle diversity.	MYH1 MYH2 MYH4	5.47e-07	11	53	3	8136524
Pubmed	Ephrin-A3 promotes and maintains slow muscle fiber identity during postnatal development and reinnervation.	MYH2 MYH4 MYH7	5.47e-07	11	53	3	26644518
Pubmed	Cleavage of human and mouse cytoskeletal and sarcomeric proteins by human immunodeficiency virus type 1 protease. Actin, desmin, myosin, and tropomyosin.	MYH6 MYH7 MYH13	7.28e-07	12	53	3	8424456
Pubmed	HOXA5 plays tissue-specific roles in the developing respiratory system.	MYH1 MYH2 MYH4 MYH7	7.48e-07	46	53	4	28827394
Pubmed	TAF7L modulates brown adipose tissue formation.	MYH1 MYH4 MYH6	9.45e-07	13	53	3	24876128
Pubmed	Calcium-binding protein 7 expressed in muscle negatively regulates age-related degeneration of neuromuscular junctions in mice.	MYH2 MYH4 MYH7	1.20e-06	14	53	3	38327785
Pubmed	skNAC, a Smyd1-interacting transcription factor, is involved in cardiac development and skeletal muscle growth and regeneration.	MYH2 MYH4 MYH7	1.20e-06	14	53	3	21071677
Pubmed	MusTRD can regulate postnatal fiber-specific expression.	MYH1 MYH2 MYH4	1.85e-06	16	53	3	16494860
Pubmed	Skeletal Muscle-Specific Methyltransferase METTL21C Trimethylates p97 and Regulates Autophagy-Associated Protein Breakdown.	MYH2 MYH4 MYH7	1.85e-06	16	53	3	29719249
Pubmed	Genesis of muscle fiber-type diversity during mouse embryogenesis relies on Six1 and Six4 gene expression.	MYH1 MYH2 MYH4 MYH7	1.92e-06	58	53	4	21884692
Pubmed	Slow and fast fiber isoform gene expression is systematically altered in skeletal muscle of the Sox6 mutant, p100H.	MYH2 MYH4 MYH7	2.24e-06	17	53	3	16124007
Pubmed	Postnatal myosin heavy chain isoform expression in normal mice and mice null for IIb or IId myosin heavy chains.	MYH1 MYH4	2.28e-06	2	53	2	11150240
Pubmed	CK2 acts as a potent negative regulator of receptor-mediated insulin release in vitro and in vivo.	CSNK2A1 CSNK2A2	2.28e-06	2	53	2	26598688
Pubmed	All-atom molecular dynamics simulations of actin-myosin interactions: a comparative study of cardiac α myosin, β myosin, and fast skeletal muscle myosin.	MYH6 MYH7	2.28e-06	2	53	2	24224850
Pubmed	Myosin heavy chain composition of the human genioglossus muscle.	MYH1 MYH2	2.28e-06	2	53	2	22337492
Pubmed	Protein kinase CK2 in mammary gland tumorigenesis.	CSNK2A1 CSNK2A2	2.28e-06	2	53	2	11423974
Pubmed	Distribution and structure-function relationship of myosin heavy chain isoforms in the adult mouse heart.	MYH6 MYH7	2.28e-06	2	53	2	17575272
Pubmed	Reversible epigenetic modifications of the two cardiac myosin heavy chain genes during changes in expression.	MYH6 MYH7	2.28e-06	2	53	2	21526716
Pubmed	Myosin heavy chain composition and the economy of contraction in healthy and diseased human myocardium.	MYH6 MYH7	2.28e-06	2	53	2	16088376
Pubmed	Functional effects of the hypertrophic cardiomyopathy R403Q mutation are different in an alpha- or beta-myosin heavy chain backbone.	MYH6 MYH7	2.28e-06	2	53	2	18480046
Pubmed	Complete sequence of human cardiac alpha-myosin heavy chain gene and amino acid comparison to other myosins based on structural and functional differences.	MYH6 MYH7	2.28e-06	2	53	2	1776652
Pubmed	Neonatal cardiomyopathy in mice homozygous for the Arg403Gln mutation in the alpha cardiac myosin heavy chain gene.	MYH6 MYH7	2.28e-06	2	53	2	9884344
Pubmed	Myosin heavy chains IIa and IId are functionally distinct in the mouse.	MYH1 MYH2	2.28e-06	2	53	2	9585413
Pubmed	Casein kinase 2 and microtubules control axon initial segment formation.	CSNK2A1 CSNK2A2	2.28e-06	2	53	2	20850541
Pubmed	Predominance of CK2α over CK2α' in the mammalian brain.	CSNK2A1 CSNK2A2	2.28e-06	2	53	2	21761202
Pubmed	Murine pulmonary myocardium: developmental analysis of cardiac gene expression.	MYH6 MYH7	2.28e-06	2	53	2	7919499
Pubmed	Role of microtubules versus myosin heavy chain isoforms in contractile dysfunction of hypertrophied murine cardiocytes.	MYH6 MYH7	2.28e-06	2	53	2	12750067
Pubmed	Endogenous slow and fast myosin dynamics in myofibers isolated from mice expressing GFP-Myh7 and Kusabira Orange-Myh1.	MYH1 MYH7	2.28e-06	2	53	2	35759444
Pubmed	Specific localization of the catalytic subunits of protein kinase CK2 at the centrosomes.	CSNK2A1 CSNK2A2	2.28e-06	2	53	2	12568341
Pubmed	Length-dependent effects on cardiac contractile dynamics are different in cardiac muscle containing α- or β-myosin heavy chain.	MYH4 MYH7	2.28e-06	2	53	2	23111184
Pubmed	Developmental and growth defects in mice with combined deficiency of CK2 catalytic genes.	CSNK2A1 CSNK2A2	2.28e-06	2	53	2	21769451
Pubmed	Diastolic dysfunction and altered energetics in the alphaMHC403/+ mouse model of familial hypertrophic cardiomyopathy.	MYH6 MYH7	2.28e-06	2	53	2	9541509
Pubmed	Myeloid Cell CK2 Regulates Inflammation and Resistance to Bacterial Infection.	CSNK2A1 CSNK2A2	2.28e-06	2	53	2	33363536
Pubmed	Characterization of diverse forms of myosin heavy chain expressed in adult human skeletal muscle.	MYH1 MYH7	2.28e-06	2	53	2	2421254
Pubmed	Functional specialization of CK2 isoforms and characterization of isoform-specific binding partners.	CSNK2A1 CSNK2A2	2.28e-06	2	53	2	11827170
Pubmed	Transgenic mouse α- and β-cardiac myosins containing the R403Q mutation show isoform-dependent transient kinetic differences.	MYH6 MYH7	2.28e-06	2	53	2	23580644
Pubmed	Long-Read Sequence Confirmed a Large Deletion Including MYH6 and MYH7 in an Infant of Atrial Septal Defect and Atrial Arrhythmias.	MYH6 MYH7	2.28e-06	2	53	2	34384224
Pubmed	Temporal spatial expression and function of non-muscle myosin II isoforms IIA and IIB in scar remodeling.	MYH2 MYH4	2.28e-06	2	53	2	21102503
Pubmed	Characterization of human cardiac myosin heavy chain genes.	MYH6 MYH7	2.28e-06	2	53	2	2726733
Pubmed	Protein kinase CK2 is involved in G2 arrest and apoptosis following spindle damage in epithelial cells.	CSNK2A1 CSNK2A2	2.28e-06	2	53	2	11704824
Pubmed	Protein kinases. 4. Protein kinase CK2: an enzyme with multiple substrates and a puzzling regulation.	CSNK2A1 CSNK2A2	2.28e-06	2	53	2	7896000
Pubmed	Okur-Chung neurodevelopmental syndrome-linked CK2α variants have reduced kinase activity.	CSNK2A1 CSNK2A2	2.28e-06	2	53	2	33944995
Pubmed	Analysis of mouse conceptuses with uniparental duplication/deficiency for distal chromosome 12: comparison with chromosome 12 uniparental disomy and implications for genomic imprinting.	MYH1 MYH2	2.28e-06	2	53	2	16575183
Pubmed	Globozoospermia in mice lacking the casein kinase II alpha' catalytic subunit.	CSNK2A1 CSNK2A2	2.28e-06	2	53	2	10471512
Pubmed	Human cardiac myosin heavy chain gene mapped within chromosome region 14q11.2----q13.	MYH6 MYH7	2.28e-06	2	53	2	2494889
Pubmed	Human cardiac myosin heavy chain genes and their linkage in the genome.	MYH6 MYH7	2.28e-06	2	53	2	3037493
Pubmed	β-myosin heavy chain is induced by pressure overload in a minor subpopulation of smaller mouse cardiac myocytes.	MYH6 MYH7	2.28e-06	2	53	2	21778428
Pubmed	Structural organization of the human cardiac alpha-myosin heavy chain gene (MYH6).	MYH6 MYH7	2.28e-06	2	53	2	8307559
Pubmed	Different pathways regulate expression of the skeletal myosin heavy chain genes.	MYH1 MYH2	2.28e-06	2	53	2	11551968
Pubmed	β-Myosin heavy chain variant Val606Met causes very mild hypertrophic cardiomyopathy in mice, but exacerbates HCM phenotypes in mice carrying other HCM mutations.	MYH6 MYH7	2.28e-06	2	53	2	24829265
Pubmed	Identification of four genomic loci highly related to casein-kinase-2-alpha cDNA and characterization of a casein kinase-2-alpha pseudogene within the mouse genome.	CSNK2A1 CSNK2A2	2.28e-06	2	53	2	1497660
Pubmed	Identification of a phosphatase activity, toward the phosphopeptide pyroGlu-Asp-Asp-Ser(p)-Asp-Glu-Glu-Asn, in nuclear extract from HL-60 promyelocitic leukaemia cells.	CSNK2A1 CSNK2A2	2.28e-06	2	53	2	10970045
Pubmed	Effects of bone fracture and surgery on plasma myosin heavy chain fragments of skeletal muscle.	MYH2 MYH7	2.28e-06	2	53	2	10579056
Pubmed	Cardiac myosin heavy chain mRNA expression and myocardial function in the mouse heart.	MYH6 MYH7	2.28e-06	2	53	2	2036722
Pubmed	Ensemble force changes that result from human cardiac myosin mutations and a small-molecule effector.	MYH6 MYH7	2.28e-06	2	53	2	25937279
Interaction	RSPH6A interactions	MYH1 MYH2 MYH4 MYH7 MYH13	2.47e-08	34	52	5	int:RSPH6A
Interaction	ZSCAN5A interactions	MYH1 MYH4 MYH7 CSNK2A1 CSNK2A2	4.42e-08	38	52	5	int:ZSCAN5A
Interaction	LATS1 interactions	MYH1 MYH2 MYH4 MYH6 MYH7 PTPN13 MYH13 CSNK2A2 ANKRD52 VDAC2	1.55e-07	440	52	10	int:LATS1
Interaction	ASAH2 interactions	MYH1 MYH4 MYH7	3.22e-07	6	52	3	int:ASAH2
Interaction	CDK3 interactions	MYH1 MYH2 MYH6 MYH7 MYH13 MYH15	4.73e-07	114	52	6	int:CDK3
Interaction	TSPAN33 interactions	MYH1 MYH2 MYH4 MYH7 MYH13	6.90e-07	65	52	5	int:TSPAN33
Interaction	PRKAG2 interactions	MYH1 MYH2 MYH4 MYH6 MYH7	8.66e-07	68	52	5	int:PRKAG2
Interaction	STK4 interactions	MYH1 MYH2 MYH6 MYH7 MYH13 MYH15	3.31e-06	159	52	6	int:STK4
Interaction	TMEM260 interactions	MYH1 MYH4 MYH7	4.55e-06	13	52	3	int:TMEM260
Interaction	ACTN2 interactions	MYH1 MYH2 MYH4 MYH6 MYH7 ST7	5.04e-06	171	52	6	int:ACTN2
Interaction	STK3 interactions	MYH1 MYH2 MYH6 MYH7 MYH13 MYH15	6.98e-06	181	52	6	int:STK3
Interaction	MYH8 interactions	MYH4 MYH6 MYH7 MYH13	9.73e-06	52	52	4	int:MYH8
Interaction	LZTR1 interactions	MYH1 MYH4 MYH6 MYH7 MYH13	9.79e-06	111	52	5	int:LZTR1
Interaction	BCAP31 interactions	MYH1 MYH2 MYH4 MYH6 MYH7 MYH13 ST7 MYH15 VDAC2	1.08e-05	554	52	9	int:BCAP31
Interaction	SLC39A3 interactions	MYH1 MYH2 MYH4 MYH7	3.19e-05	70	52	4	int:SLC39A3
Interaction	LACTB2 interactions	MYH1 MYH4 MYH7 MYH13	5.94e-05	82	52	4	int:LACTB2
Interaction	FKBP6 interactions	MYH1 MYH4 MYH7 CCDC198	7.16e-05	86	52	4	int:FKBP6
Interaction	HSPB8 interactions	MYH1 MYH2 MYH4 MYH6 CSNK2A1	8.03e-05	172	52	5	int:HSPB8
Interaction	GRIN2A interactions	ABCB9 ST7 CSNK2A1 CSNK2A2	9.71e-05	93	52	4	int:GRIN2A
Interaction	SNRK interactions	MYH1 MYH2 CSNK2A1	1.00e-04	35	52	3	int:SNRK
Interaction	SBDS interactions	MYH1 MYH2 MYH4 MYH7 MYH13	1.02e-04	181	52	5	int:SBDS
Interaction	AKAP17A interactions	MYH4 MYH7 CSNK2A1 CSNK2A2	1.24e-04	99	52	4	int:AKAP17A
Interaction	ABTB2 interactions	MYH1 MYH2 MYH4 MYH6	1.34e-04	101	52	4	int:ABTB2
Interaction	MEGF9 interactions	MYH4 DPP9	1.36e-04	7	52	2	int:MEGF9
Interaction	PRKACB interactions	MYH1 MYH2 MYH4 MYH6 CSNK2A1	1.38e-04	193	52	5	int:PRKACB
Interaction	BHLHE41 interactions	MYH13 CSNK2A1 CSNK2A2	1.50e-04	40	52	3	int:BHLHE41
Interaction	AURKC interactions	MYH1 MYH4 MYH7	1.86e-04	43	52	3	int:AURKC
Interaction	ZDHHC4 interactions	CLDND1 ZDHHC4	2.32e-04	9	52	2	int:ZDHHC4
Interaction	F2RL3 interactions	CSNK2A1 CSNK2A2	2.32e-04	9	52	2	int:F2RL3
Interaction	CT45A3 interactions	CSNK2A1 CSNK2A2	2.32e-04	9	52	2	int:CT45A3
Interaction	LYZL1 interactions	HFE EOGT GALNT12 ZZEF1	2.43e-04	118	52	4	int:LYZL1
Interaction	EFCAB14 interactions	CSNK2A1 CSNK2A2	2.90e-04	10	52	2	int:EFCAB14
Interaction	PTPRU interactions	HFE NHSL1 PTPN13 ST7	2.94e-04	124	52	4	int:PTPRU
Interaction	MECOM interactions	MYH1 MYH2 MYH4 MYH7 CSNK2A1 CSNK2A2	3.08e-04	358	52	6	int:MECOM
Interaction	MYH3 interactions	MYH4 MYH6 MYH7	3.28e-04	52	52	3	int:MYH3
Interaction	LYST interactions	MYH13 CSNK2A1 CSNK2A2	3.47e-04	53	52	3	int:LYST
Interaction	PTPN4 interactions	CSNK2A1 CSNK2A2 ZZEF1	3.66e-04	54	52	3	int:PTPN4
Interaction	ANKRD36C interactions	CSNK2A1 CSNK2A2	4.24e-04	12	52	2	int:ANKRD36C
Interaction	PPP1R1B interactions	CSNK2A1 CSNK2A2	4.24e-04	12	52	2	int:PPP1R1B
Interaction	ANKRD36B interactions	CSNK2A1 CSNK2A2 TTK	5.00e-04	60	52	3	int:ANKRD36B
Interaction	IPMK interactions	CSNK2A1 CSNK2A2	5.00e-04	13	52	2	int:IPMK
Interaction	HAGHL interactions	CSNK2A1 CSNK2A2	5.00e-04	13	52	2	int:HAGHL
Interaction	ZXDA interactions	CSNK2A1 CSNK2A2	5.00e-04	13	52	2	int:ZXDA
Cytoband	Ensembl 112 genes in cytogenetic band chr17p13	MYH1 MYH2 MYH4 MYH13 CTNS WRAP53 ZZEF1	1.49e-07	346	53	7	chr17p13
Cytoband	17p13.1	MYH1 MYH2 MYH4 WRAP53	1.10e-05	118	53	4	17p13.1
Cytoband	17p13	MYH13 CTNS	7.16e-04	34	53	2	17p13
Cytoband	Ensembl 112 genes in cytogenetic band chr12q24	ABCB9 RNFT2 ADGRD1 MORN3	1.36e-03	415	53	4	chr12q24
Cytoband	14q12	MYH6 MYH7	1.87e-03	55	53	2	14q12
Cytoband	Ensembl 112 genes in cytogenetic band chr5q12	NLN ELOVL7	2.68e-03	66	53	2	chr5q12
GeneFamily	Myosin heavy chains	MYH1 MYH2 MYH4 MYH6 MYH7 MYH13 MYH15	2.74e-16	15	34	7	1098
GeneFamily	Polypeptide N-acetylgalactosaminyltransferases	GALNT12 GALNT4	6.38e-04	20	34	2	433
Coexpression	HUMMERICH_BENIGN_SKIN_TUMOR_DN	MYH1 MYH2 MYH4	8.69e-06	20	53	3	M1123
Coexpression	HUMMERICH_BENIGN_SKIN_TUMOR_DN	MYH1 MYH2 MYH4	1.01e-05	21	53	3	MM1102
ToppCell	Thalamus-Neuronal-Excitatory-eN2(Slc17a7_Slc17a6)-Slc17a7-Tac2-Excitatory_Neuron.Slc17a7.Tac2.Syt15_(Medial_habenula)\|Thalamus / BrainAtlas - Mouse McCarroll V32	MYH1 MYH2 MYH4 MYH6 MYH13	3.46e-08	77	53	5	7f624e9262bd0dc2ac4176f43c91a4bc0f521fe5
ToppCell	facs-Marrow-T_cells-18m-Hematologic-megakaryocyte-erythroid_progenitor_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PTPN13 CD300E DSE GABRA4	3.57e-05	156	53	4	5caefdc6cc86f2ac52abe8c8da821db14f476915
ToppCell	facs-Marrow-T_cells-18m-Hematologic-megakaryocyte-erythroid_progenitor_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PTPN13 CD300E DSE GABRA4	3.57e-05	156	53	4	758f57dc10fc5cad200bf5b310c10ec9b1405f23
ToppCell	normal_Lung-B_lymphocytes-MALT_B_cells\|normal_Lung / Location, Cell class and cell subclass	ABCB9 IGHV1-69-2 MYH15 KLHL14	3.84e-05	159	53	4	fbd0131b66f4267f7b0d6c3ad874ad097b859074
ToppCell	Hippocampus-Neuronal-Inhibitory-iN2(Gad1Gad2)-Grm1-Inhibitory_Neuron.Gad1Gad2_Sst.Grm1_(Interneuron,_OLM3_(CA1_enriched?))-\|Hippocampus / BrainAtlas - Mouse McCarroll V32	MYH4 MYH13 KLHL14	3.88e-05	55	53	3	10e98fc862d89141512bdebae1231ef1a82105b0
ToppCell	Hippocampus-Neuronal-Inhibitory-iN2(Gad1Gad2)-Grm1-Inhibitory_Neuron.Gad1Gad2_Sst.Grm1_(Interneuron,_OLM3_(CA1_enriched?))\|Hippocampus / BrainAtlas - Mouse McCarroll V32	MYH4 MYH13 KLHL14	3.88e-05	55	53	3	a55d3edca2dd9ca7a703b2b3a5941b30b5f0a6df
ToppCell	Hippocampus-Neuronal-Inhibitory-iN2(Gad1Gad2)-Grm1\|Hippocampus / BrainAtlas - Mouse McCarroll V32	MYH4 MYH13 KLHL14	3.88e-05	55	53	3	bac333ea3914a49376105dd977a0b8493b0d2001
ToppCell	primary_visual_cortex-Neuronal-GABAergic_neuron-Sst\|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	MYH1 MYH4 MYH13 KLHL14	4.99e-05	170	53	4	8ab67e2b6e30fdf9e9a2c02e31d4df34e751a3ed
ToppCell	Frontal_cortex-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Sst-Inhibitory_Neuron.Gad1Gad2.Sst-Nr2f2_(MGE-derived_cortical_interneurons--Martinotti_cells)\|Frontal_cortex / BrainAtlas - Mouse McCarroll V32	MYH1 MYH4 MYH13	5.56e-05	62	53	3	a20620a8869721ea62984c2022ee1b484b455824
ToppCell	Frontal_cortex-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Sst-Inhibitory_Neuron.Gad1Gad2.Sst-Nr2f2_(MGE-derived_cortical_interneurons--Martinotti_cells)-\|Frontal_cortex / BrainAtlas - Mouse McCarroll V32	MYH1 MYH4 MYH13	5.56e-05	62	53	3	ee694c06bcd924b4ddf744178ba3a99e04eed51b
ToppCell	Posterior_cortex-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Sst\|Posterior_cortex / BrainAtlas - Mouse McCarroll V32	MYH4 MYH13 KLHL14	5.83e-05	63	53	3	55f11bb2970a8159166e71af34a0446ecee594e6
ToppCell	Hippocampus-Neuronal-Excitatory-eN2(Slc17a7_Slc17a6)-Slc17a6-Excitatory_Neuron.Slc17a6.Grp_(Neuron.Slc17a6.Grp)-\|Hippocampus / BrainAtlas - Mouse McCarroll V32	MYH1 MYH2 MYH6	6.40e-05	65	53	3	b7bc23af54d6d2f7afd584f4df42c24d7c49e344
ToppCell	Hippocampus-Neuronal-Excitatory-eN2(Slc17a7_Slc17a6)-Slc17a6-Excitatory_Neuron.Slc17a6.Grp_(Neuron.Slc17a6.Grp)\|Hippocampus / BrainAtlas - Mouse McCarroll V32	MYH1 MYH2 MYH6	6.40e-05	65	53	3	3b3630253f5713c4a688c74c4ea0f98c1fe42594
ToppCell	Hippocampus-Neuronal-Excitatory-eN2(Slc17a7_Slc17a6)-Slc17a6-Excitatory_Neuron.Slc17a6.Htr1a_(Neuron.Slc17a6.Htr1a)-\|Hippocampus / BrainAtlas - Mouse McCarroll V32	MYH1 MYH2 TEX19	7.01e-05	67	53	3	be6853b5bf254063f02a4c478fd4c3fef68cb77a
ToppCell	Hippocampus-Neuronal-Excitatory-eN2(Slc17a7_Slc17a6)-Slc17a6-Excitatory_Neuron.Slc17a6.Htr1a_(Neuron.Slc17a6.Htr1a)\|Hippocampus / BrainAtlas - Mouse McCarroll V32	MYH1 MYH2 TEX19	7.01e-05	67	53	3	7483b85423d9d07b01b60927d0fe1b7ccb241d7f
ToppCell	facs-Trachea-18m-Mesenchymal-fibroblast-fibroblast_of_trachea-\|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	MYH1 MYH2 MYH4 MYH13	7.07e-05	186	53	4	bdc87e4631a8ea73e262e541aa84a28f24c94b00
ToppCell	Posterior_cortex-Macroglia-ASTROCYTE-Gja1-Astrocyte.Gja1.Myoc_(Myoc)\|Posterior_cortex / BrainAtlas - Mouse McCarroll V32	SLC25A21 MYH15 MORN3	7.65e-05	69	53	3	8e14f411cbaea9cb9bcb9351b2421e71d5828ccc
ToppCell	Posterior_cortex-Macroglia-ASTROCYTE-Gja1-Astrocyte.Gja1.Myoc_(Myoc)--\|Posterior_cortex / BrainAtlas - Mouse McCarroll V32	SLC25A21 MYH15 MORN3	7.65e-05	69	53	3	2fd6df70cdc7477e4a3ebdf4537279a727ab1214
ToppCell	Posterior_cortex-Macroglia-ASTROCYTE-Gja1-Astrocyte.Gja1.Myoc_(Myoc)-\|Posterior_cortex / BrainAtlas - Mouse McCarroll V32	SLC25A21 MYH15 MORN3	7.65e-05	69	53	3	bc3170409d107c39534581d2f0b8d75f93519113
ToppCell	distal-Hematologic-B_cell-2\|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	ABCB9 MYH15 KLHL14 DNAH8	8.15e-05	193	53	4	202dc5ec2437602c15658074728c5f5aeeab0466
ToppCell	severe-B_cell\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	KLHL14 DNAH8 ZDHHC4 ELOVL7	8.32e-05	194	53	4	2fee6083fb56b16d1f04fd0b92ec622fd26ba3fa
ToppCell	distal-2-Hematologic-B_cell\|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	ABCB9 MYH15 KLHL14 DNAH8	8.65e-05	196	53	4	2587b5d83fb4f1c4a69894aa0f5f7cb3898faa09
ToppCell	control-Myeloid-Non-resident_Macrophage\|Myeloid / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls	TSPO CHD1 CD300E DSE	8.83e-05	197	53	4	df2fe36cb96e2565a9d21c24cb4e451e8befd4be
ToppCell	Parenchymal-NucSeq-Epithelial-Epi_alveolar\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	NHSL1 PTPN13 ST7 DESI2	9.18e-05	199	53	4	8587bd98de7767a575088afbea07a1feb4516b9b
Drug	fast white	MYH1 MYH2 MYH4 MYH6 MYH7 MYH13	5.19e-10	42	52	6	CID000024008
Drug	formycin triphosphate	MYH1 MYH2 MYH4 MYH6 MYH7 MYH13	1.75e-09	51	52	6	CID000122274
Drug	purealin	MYH1 MYH2 MYH4 MYH6 MYH7 MYH13	3.89e-09	58	52	6	CID006419303
Drug	oxovanadium	MYH1 MYH2 MYH4 MYH6 MYH7 MYH13 CTNS	1.04e-08	120	52	7	CID000024411
Drug	creatine	MYH1 MYH2 MYH4 MYH6 MYH7 MYH13 CLDN12 VDAC2	1.26e-08	193	52	8	CID000000586
Drug	SM-2	MYH1 MYH2 MYH4 MYH6 MYH7 MYH13	4.62e-08	87	52	6	CID000486033
Drug	K-Cl	BLMH MYH1 MYH2 NLN MYH4 MYH6 MYH7 MYH13 CSNK2A1 CSNK2A2 VDAC2	4.97e-08	567	52	11	CID000004873
Drug	S-(-)-Etomoxir	MYH1 MYH2 MYH4 MYH6 MYH7 MYH13	1.07e-07	100	52	6	CID000060765
Drug	blebbistatin	MYH1 MYH2 MYH4 MYH6 MYH7 MYH13	2.58e-07	116	52	6	CID003476986
Drug	B0683	MYH1 MYH2 MYH4 MYH6 MYH7 MYH13	2.72e-07	117	52	6	CID006398969
Drug	2bq7	MYH1 MYH2 MYH4 MYH6 MYH7 MYH13	3.65e-07	123	52	6	CID006540267
Drug	4-chloroaniline	BLMH MYH1 MYH2 MYH4 MYH6 MYH7 MYH13	3.72e-07	202	52	7	CID000007812
Drug	AC1LADJ6	MYH1 MYH2 MYH4 MYH6 MYH7 MYH13	5.06e-07	130	52	6	CID000486032
Drug	AC1NRBPQ	MYH1 MYH2 MYH4 MYH6 MYH7 MYH13	6.90e-07	137	52	6	CID005288569
Drug	clenbuterol	MYH1 MYH2 MYH4 MYH6 MYH7 MYH13	8.51e-07	142	52	6	CID000002783
Drug	candesartan cilexetil	MYH1 MYH2 MYH4 MYH6 MYH7 MYH13	9.62e-07	145	52	6	CID000002540
Drug	AC1N9ZZC	MYH1 MYH2 MYH4 MYH6 MYH7 MYH13	1.13e-06	149	52	6	CID004369374
Drug	MgCl2	MYH1 MYH2 MYH4 MYH6 MYH7 MYH13 CSNK2A1 CSNK2A2	1.31e-06	354	52	8	CID000024584
Drug	carvedilol	MYH1 MYH2 MYH4 MYH6 MYH7 MYH13	1.77e-06	161	52	6	CID000002585
Drug	allyl phosphate	CSNK2A1 CSNK2A2	5.12e-06	2	52	2	CID000015390
Drug	AC1L1IZ2	MYH1 MYH2 MYH4 MYH6 MYH7 SETX MYH13	5.65e-06	304	52	7	CID000004795
Drug	Fluorocurarine chloride [22273-09-2]; Up 200; 11.6uM; MCF7; HT_HG-U133A	HFE MYH7 RNFT2 ST7 DESI2 WRAP53	5.68e-06	197	52	6	6219_UP
Drug	trifluoperazine	MYH1 MYH2 MYH4 MYH6 MYH7 SLC25A21 MYH13	8.56e-06	324	52	7	CID000005566
Drug	1-ethyl-4-carbamoyl-5-methylcarbamoylimidazole	CSNK2A1 CSNK2A2	1.53e-05	3	52	2	CID000130883
Drug	zolazepam	TSPO TTK GABRA4	1.93e-05	23	52	3	CID000035775
Drug	NSC339663	MYH1 MYH2 MYH4 MYH6 MYH7 MYH13	2.20e-05	250	52	6	CID000003892
Drug	CP44	CSNK2A1 CSNK2A2	3.06e-05	4	52	2	CID000452111
Drug	B501	CSNK2A1 CSNK2A2	3.06e-05	4	52	2	CID000054108
Drug	mephobarbital	BLMH TSPO GABRA4	3.54e-05	28	52	3	CID000008271
Drug	nifedipine	HFE MYH1 MYH2 MYH4 MYH6 MYH7 MYH13	4.19e-05	415	52	7	CID000004485
Drug	allylglycine	SLC25A21 TSPO GABRA4	4.37e-05	30	52	3	CID000014044
Drug	NSC9700	MYH1 MYH2 MYH4 MYH6 MYH7 SLC25A21 MYH13 TEX19	4.62e-05	578	52	8	CID000005408
Drug	NSC-122818	CSNK2A1 CSNK2A2	5.09e-05	5	52	2	CID000275783
Drug	australifungin	CSNK2A1 CSNK2A2	5.09e-05	5	52	2	CID005276375
Drug	2-methyl-3-furanthiol	XPNPEP2 DSE	5.09e-05	5	52	2	CID000034286
Drug	NSC226080	MYH1 MYH2 MYH4 MYH6 MYH7 SLC25A21 MYH13 CSNK2A1 CSNK2A2	6.21e-05	782	52	9	CID000005040
Drug	NSC107658	MYH1 MYH2 MYH4 MYH6 MYH7 MYH13	6.79e-05	306	52	6	CID000002919
Drug	FGIN-1-27	TSPO VDAC2 GABRA4	7.61e-05	36	52	3	CID000132496
Drug	GC 1 compound	MYH6 MYH7	7.63e-05	6	52	2	ctd:C413355
Drug	Flunitrazepam	TSPO GABRA4	7.63e-05	6	52	2	DB01544
Drug	(-)-depudecin; Up 200; 1uM; MCF7; HT_HG-U133A_EA	HFE SLC25A21 RNFT2 CSNK2A2 DESI2	7.82e-05	193	52	5	982_UP
Drug	Niflumic acid [4394-00-7]; Down 200; 14.2uM; MCF7; HT_HG-U133A	HFE PTPN13 THOP1 ST7 CTNS	8.41e-05	196	52	5	7430_DN
Drug	Furaltadone hydrochloride [3759-92-0]; Down 200; 11uM; HL60; HT_HG-U133A	HFE EOGT MYH15 CTNS WRAP53	8.61e-05	197	52	5	2554_DN
Drug	Probucol [23288-49-5]; Up 200; 7.8uM; MCF7; HT_HG-U133A	HFE ABCB9 GALNT12 MINAR1 ZZEF1	8.82e-05	198	52	5	3223_UP
Drug	estradiol, USP; Up 200; 0.1uM; PC3; HT_HG-U133A	HFE MYH2 MYH6 SLC25A21 ABCB9	8.82e-05	198	52	5	4432_UP
Drug	Sulfamethoxypyridazine [80-35-3]; Down 200; 14.2uM; HL60; HT_HG-U133A	HFE GALNT12 MINAR1 WRAP53 MFN1	9.03e-05	199	52	5	2550_DN
Drug	nocodazole	MYH1 MYH2 MYH4 MYH6 MYH7 MYH13 TTK	1.00e-04	477	52	7	CID000004122
Drug	I Qa	CSNK2A1 CSNK2A2	1.07e-04	7	52	2	CID000447682
Drug	verapamil	MYH1 MYH2 MYH4 MYH6 MYH7 MYH13 ABCB9	1.19e-04	490	52	7	CID000002520
Drug	PK11195	TSPO VDAC2 GABRA4	1.21e-04	42	52	3	CID000001345
Drug	Ro 5-4864	TSPO VDAC2 GABRA4	1.39e-04	44	52	3	CID000001688
Drug	Flumazenil	TSPO GABRA4	1.42e-04	8	52	2	ctd:D005442
Drug	integric acid	CSNK2A1 CSNK2A2	1.42e-04	8	52	2	CID006475378
Drug	AC1O5LBH	CSNK2A1 CSNK2A2	1.42e-04	8	52	2	CID006436254
Drug	NSC611747	MYH1 MYH2 MYH4 MYH6 MYH7 MYH13	1.46e-04	352	52	6	CID000002534
Drug	N-ethylmaleimide	BLMH MYH1 MYH2 MYH4 MYH6 MYH7 MYH13	1.54e-04	511	52	7	CID000004362
Drug	Gly-D-Phe	BLMH THOP1 DPP9	1.59e-04	46	52	3	CID000092953
Drug	3'-hydroxydaidzein	CSNK2A1 CSNK2A2	1.82e-04	9	52	2	CID005284648
Drug	IdB 1031	CSNK2A1 CSNK2A2	1.82e-04	9	52	2	CID000125309
Drug	RPR103611	CSNK2A1 CSNK2A2	1.82e-04	9	52	2	CID000072411
Drug	eye gene	MYH1 MYH2 MYH4 MYH6 MYH7 MYH13	1.89e-04	369	52	6	CID000004782
Drug	di-t-butylphosphite	CSNK2A1 CSNK2A2	2.28e-04	10	52	2	CID000518693
Drug	Clonazepam	TSPO GABRA4	2.28e-04	10	52	2	DB01068
Drug	2-amino-5-(N-ethylcarboxyamido)-pentanoic acid	CSNK2A1 CSNK2A2	2.28e-04	10	52	2	CID000194789
Drug	CKI-8	CSNK2A1 CSNK2A2	2.28e-04	10	52	2	CID000486026
Drug	copper nitrate	BLMH TSPO	2.28e-04	10	52	2	CID000018616
Drug	8-chloro-3',4',5,7-tetrahydroxyisoflavone	CSNK2A1 CSNK2A2	2.28e-04	10	52	2	CID005486848
Drug	Asptpsa	CSNK2A1 CSNK2A2	2.28e-04	10	52	2	CID000132853
Drug	time t	BLMH NLN THOP1	2.43e-04	53	52	3	CID000004790
Drug	Alprazolam	TSPO GABRA4	2.78e-04	11	52	2	DB00404
Drug	Temazepam	TSPO GABRA4	2.78e-04	11	52	2	DB00231
Drug	Lorazepam	TSPO GABRA4	2.78e-04	11	52	2	DB00186
Drug	Triazolam	TSPO GABRA4	2.78e-04	11	52	2	DB00897
Drug	Clorazepate	TSPO GABRA4	2.78e-04	11	52	2	DB00628
Drug	D-triiodothyronine	MYH1 MYH2 MYH4 MYH6 MYH7 MYH13	3.28e-04	409	52	6	CID000000861
Drug	HDMF	TSPO DSE	3.33e-04	12	52	2	CID000019309
Drug	methylglyoxal bis(guanylhydrazone	SLC25A21 CSNK2A1 CSNK2A2	3.68e-04	61	52	3	CID000009991
Drug	4-epidoxorubicin	MYH1 MYH2 MYH4 MYH6 MYH7 PTPN13 MYH13 CHD1	3.88e-04	788	52	8	CID000001690
Drug	AC1L4M5O	CSNK2A1 CSNK2A2	3.93e-04	13	52	2	CID000159625
Drug	5-chloroisoquinoline	CSNK2A1 CSNK2A2	3.93e-04	13	52	2	CID000224933
Drug	cinolazepam	TSPO GABRA4	3.93e-04	13	52	2	CID003033621
Disease	dilated cardiomyopathy 1S (implicated_via_orthology)	MYH1 MYH2 MYH4 MYH6 MYH7 MYH13 MYH15	3.58e-18	10	51	7	DOID:0110454 (implicated_via_orthology)
Disease	distal arthrogryposis type 2B3 (implicated_via_orthology)	MYH1 MYH2 MYH4 MYH6 MYH7 MYH13 MYH15	3.58e-18	10	51	7	DOID:0111602 (implicated_via_orthology)
Disease	inclusion body myositis (implicated_via_orthology)	MYH1 MYH2 MYH4 MYH6 MYH7 MYH13 MYH15	3.58e-18	10	51	7	DOID:3429 (implicated_via_orthology)
Disease	autosomal dominant hyaline body myopathy (implicated_via_orthology)	MYH1 MYH2 MYH4 MYH6 MYH7 MYH13 MYH15	3.58e-18	10	51	7	DOID:0111269 (implicated_via_orthology)
Disease	congenital myopathy 6 (implicated_via_orthology)	MYH1 MYH2 MYH4 MYH6 MYH7 MYH13 MYH15	3.58e-18	10	51	7	DOID:0080719 (implicated_via_orthology)
Disease	distal arthrogryposis type 2A (implicated_via_orthology)	MYH1 MYH2 MYH4 MYH6 MYH7 MYH13 MYH15	3.58e-18	10	51	7	DOID:0111605 (implicated_via_orthology)
Disease	familial hypertrophic cardiomyopathy (implicated_via_orthology)	MYH1 MYH2 MYH4 MYH6 MYH7 MYH13 MYH15	3.58e-18	10	51	7	DOID:0080326 (implicated_via_orthology)
Disease	distal arthrogryposis type 1 (implicated_via_orthology)	MYH1 MYH2 MYH4 MYH6 MYH7 MYH13 MYH15	3.58e-18	10	51	7	DOID:0111596 (implicated_via_orthology)
Disease	distal myopathy (implicated_via_orthology)	MYH1 MYH2 MYH4 MYH6 MYH7 MYH13 MYH15	2.36e-17	12	51	7	DOID:11720 (implicated_via_orthology)
Disease	myotonia congenita (implicated_via_orthology)	MYH1 MYH2 MYH4 MYH6 MYH7 MYH13 MYH15	2.36e-17	12	51	7	DOID:2106 (implicated_via_orthology)
Disease	restrictive cardiomyopathy (implicated_via_orthology)	MYH1 MYH2 MYH4 MYH6 MYH7 MYH13 MYH15	5.10e-17	13	51	7	DOID:397 (implicated_via_orthology)
Disease	distal arthrogryposis (implicated_via_orthology)	MYH1 MYH2 MYH4 MYH6 MYH7 MYH13 MYH15	1.91e-16	15	51	7	DOID:0050646 (implicated_via_orthology)
Disease	myopathy (implicated_via_orthology)	MYH1 MYH2 MYH4 MYH6 MYH7 MYH13 MYH15	2.09e-12	48	51	7	DOID:423 (implicated_via_orthology)
Disease	cardiomyopathy (implicated_via_orthology)	MYH1 MYH2 MYH4 MYH6 MYH7 MYH13 MYH15	3.67e-11	71	51	7	DOID:0050700 (implicated_via_orthology)
Disease	dilated cardiomyopathy (implicated_via_orthology)	MYH1 MYH2 MYH4 MYH6 MYH7 MYH13 MYH15	8.66e-11	80	51	7	DOID:12930 (implicated_via_orthology)
Disease	Caveolinopathy	MYH6 MYH7	1.75e-05	4	51	2	cv:C5679790
Disease	Cardiomyopathy, Familial Hypertrophic, 1 (disorder)	MYH6 MYH7	1.75e-05	4	51	2	C3495498
Disease	Hypertrophic cardiomyopathy 1	MYH6 MYH7	1.75e-05	4	51	2	cv:C3495498
Disease	CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 1	MYH6 MYH7	1.75e-05	4	51	2	192600
Disease	colorectal cancer (is_implicated_in)	HFE PTPN13 GALNT12 WRAP53	5.79e-05	121	51	4	DOID:9256 (is_implicated_in)
Disease	Idiopathic hypertrophic subaortic stenosis	MYH6 MYH7	6.12e-05	7	51	2	C0700053
Disease	Obstructive asymmetric septal hypertrophy	MYH6 MYH7	6.12e-05	7	51	2	C0597124
Disease	Cardiomyopathy, Familial Idiopathic	HFE MYH6 MYH7	9.00e-05	50	51	3	C1449563
Disease	Cardiomyopathy, Hypertrophic, Familial	MYH6 MYH7	1.05e-04	9	51	2	C0949658
Disease	Muscular dystrophy, limb-girdle, autosomal dominant	MYH6 MYH7	1.31e-04	10	51	2	cv:C5675009
Disease	head and neck squamous cell carcinoma (is_implicated_in)	PTPN13 WRAP53	3.03e-04	15	51	2	DOID:5520 (is_implicated_in)
Disease	cardiomyopathy (is_implicated_in)	HFE MYH7	4.92e-04	19	51	2	DOID:0050700 (is_implicated_in)
Disease	Primary familial hypertrophic cardiomyopathy	MYH6 MYH7	6.62e-04	22	51	2	cv:C0949658
Disease	Hypertrophic obstructive cardiomyopathy	MYH6 MYH7	8.57e-04	25	51	2	C4551472
Disease	Limb-girdle muscular dystrophy	MYH6 MYH7	9.27e-04	26	51	2	cv:C0686353
Disease	Primary familial dilated cardiomyopathy	MYH6 MYH7	1.24e-03	30	51	2	cv:C0340427
Disease	Squamous cell carcinoma	CSNK2A1 CSNK2A2 VDAC2	1.30e-03	124	51	3	C0007137
Disease	Heart Failure, Diastolic	MYH6 MYH7	1.49e-03	33	51	2	C1135196
Disease	Primary dilated cardiomyopathy	MYH6 MYH7	1.59e-03	34	51	2	cv:C0007193

Protein segments in the cluster

Peptide	Gene	Start	Entry
YDYGIDMWSVGCTLY	PRPF4B	866	Q13523
YIVMWDTSSYGYGDL	EOGT	271	Q5NDL2
GSEDSKHRYYYGMGW	ADGRD1	666	Q6QNK2
SLTVWCQYESMYKGY	CD300E	31	Q496F6
GVDYSGYSPMHWASY	ANKRD52	786	Q8NB46
LLIGIYEYGYGSWEM	CHD1	1261	O14646
VYDMYWMNEYTSSIG	DESI2	11	Q9BSY9
KDRYGSWMIYTYSGL	MYH7	106	P12883
MYGALYLYERLSWTT	MFN1	621	Q8IWA4
GAVMLLVYEYTYSWL	SLC25A21	281	Q9BQT8
TGDLTMFYYGDWLSQ	LOXHD1	1641	Q8IVV2
TDPWGYYIDYTGMQE	NHSL1	781	Q5SYE7
LKERYAAWMIYTYSG	MYH2	106	Q9UKX2
NQTMYEFYVTDYGDW	DNAH8	2391	Q96JB1
EGVYIYGLYMDGAAW	DNAH8	4396	Q96JB1
DGLYKMYWMDDTGYS	DSE	611	Q9UL01
GSYAYPKSEMIYTWT	GABRA4	191	P48169
LKERYAAWMIYTYSG	MYH1	106	P12882
MQEDNSTEGYWKYGY	HFE	126	Q30201
CKVSGYTFTDYYMHW	IGHV1-69-2	41	A0A0G2JMI3
SIYLVGGYSWSMGAY	KLHL14	571	Q9P2G3
YMCYEFVMSGWGIGY	ELOVL7	81	A1L3X0
VTVWMAYDTGYTERY	DPP9	756	Q86TI2
FQYLGTYDTGMEVWG	GALNT4	321	Q8N4A0
YFEYLGSYDTGMEVW	GALNT12	321	Q8IXK2
DYQMYDYSLDMWSLG	CSNK2A2	206	P19784
GYLCMTDEWFSEYVY	BLMH	406	Q13867
YQMYDYSLDMWSLGC	CSNK2A1	206	P68400
YMNFYYKSTEGWSIG	CTNS	286	O60931
YDGSSDCLMYDTTWY	CLDN12	61	P56749
ENWYGRYSTASRDMY	CCDC198	66	Q9NVL8
WGRMYYSNGDIYEGQ	MORN3	126	Q6PF18
IYSLGMTLYWGADYE	PTPN13	101	Q12923
VYGYLMKYTNLVTGW	OSBPL11	61	Q9BXB4
LEYWMEDIYTPGYDS	MINAR1	861	Q9UPX6
LWYKYIMGDDSSNSY	RNFT2	316	Q96EX2
VEGDTIYDYCWYSLM	WRAP53	221	Q9BUR4
RYGQWMIYTYSGLFC	MYH15	126	Q9Y2K3
VGFAMYYFTYDSWTG	SATL1	596	Q86VE3
SHMYDTTNYKSYWLG	SETX	226	Q7Z333
LKERYAAWMIYTYSG	MYH4	106	Q9Y623
YTWVTGREPLTYYDM	ST7	151	Q9NRC1
KERYAAWMIYTYSGL	MYH6	106	P13533
AAAYMYYVWGSGLTL	ABCB9	406	Q9NP78
IYMAASIGTDFWYEY	CLDND1	21	Q9NY35
GQYYGYLWSEVFSMD	NLN	631	Q9BYT8
QGMVYTEYTWEVFGY	ZDHHC4	76	Q9NPG8
GYEGWLAGYQMTFDS	VDAC2	156	P45880
LKERYAAWMIYTYSG	MYH13	106	Q9UKX3
DVWSLGCILYYMTYG	TTK	716	P33981
YYRFTSDMSNTEWGY	ZZEF1	2776	O43149
YHYQLGLTYWFMGEE	TTC37	456	Q6PGP7
RIWIGTSYTMYGIYE	XPNPEP2	321	O43895
DAQYYGYLWSEVYSM	THOP1	606	P52888
EEGMSYLYASWMYQL	TEX19	11	Q8NA77
LYSAMGYGSYLVWKE	TSPO	56	P30536